Ignite Creation Date:
2024-05-05 @ 10:48 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01196442
Status:
COMPLETED
Last Update Posted:
2013-08-23
First Post:
2010-09-03
Brief Title:
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Study Overview
Official Title:
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy PURPOSE This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer
Detailed Description:
OBJECTIVES
I To evaluate the effect of MC5-A on pain symptoms both immediately and over time
II To evaluate the effect of Calmare therapy on other non-pain symptoms III To evaluate the effect of MC5-A on daily opioid and other pain medication use
OUTLINE Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days After completion of study treatment patients are followed up for 3 months
I To evaluate the effect of MC5-A on pain symptoms both immediately and over time
II To evaluate the effect of Calmare therapy on other non-pain symptoms III To evaluate the effect of MC5-A on daily opioid and other pain medication use
OUTLINE Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days After completion of study treatment patients are followed up for 3 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2010-01945 | REGISTRY | CTRP | None |